Evidence map›Paper›PMID 40637161›Full record

ArticleHuman vaccines & immunotherapeutics2025

Vaccine hesitancy and economic hardship: A latent class analysis of racial and ethnic minority communities at high risk of COVID-19 infection in Southern California.

Britt Skaathun, Christian I Rodríguez-Rosales, Grethel Gahbler-Lopez, Scott R Furtwengler, Linda Salgin, Fatima A Muñoz, Davey M Smith, Jamila K Stockman, Sophie E O'Bryan, Daniel Ramirez and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05022472 (Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05022472 phase4completednot on this map

Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California

TypeinterventionalSponsorBritt SkaathunRan2021 to 2024Enrolled1,051ConditionsVaccine Refusal, Covid19ArmsCOVID-19 Individual Awareness and Education., COVID-19 Community Outreach & Health Promotion., COVID-19 Individual Health Education & Linkages to Medical and Supportive Services., Pop-up community vaccination sites
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Britt SkaathunSchool of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, USA.
Christian I Rodríguez-RosalesSan Ysidro Health, San Diego, CA, USA.
Grethel Gahbler-LopezSan Ysidro Health, San Diego, CA, USA.
Scott R FurtwenglerSchool of Professional Advancement, Tulane University, New Orleans, LA, USA.
Linda SalginSan Ysidro Health, San Diego, CA, USA.
Fatima A MuñozSan Ysidro Health, San Diego, CA, USA.
Davey M SmithSchool of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, USA.
Jamila K StockmanSchool of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, USA.
Sophie E O'BryanSchool of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, USA.
Daniel RamirezSan Ysidro Health, San Diego, CA, USA.
Cynthia James-PriceMulticultural Health Foundation, San Diego, CA, USA.
Argentina E ServinSchool of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, USA.

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern CaliforniaR01MD016872 · NIMHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SKAATHUN, BRITT · 2021 to 2025
$3.1M
NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214NIMHD NIH HHS R01 MD016872
6 · The paper itself

Abstract

We examined the association between economic hardship and vaccine hesitancy among communities at high risk of COVID-19 infection. We used latent class analysis to calculate the predicted probability of belonging in a high or low vaccine hesitancy group using nine vaccine belief and behavior survey items using data from clinical trial NCT05022472. An economic hardship index was constructed to assess whether experiencing one or more economic hardships during the COVID-19 pandemic was associated with high vaccine hesitancy using a multivariable logistic regression model. Overall, 39% of participants remained highly vaccine hesitant despite vaccine uptake exceeding 97%, highlighting the important distinction between uptake and hesitancy. Having experienced at least one economic hardship significantly increased the adjusted odds of high vaccine hesitancy, compared to not experiencing any economic hardships. Employment, infection history, education, and vaccine series completion factors were also salient factors associated with high vaccine hesitancy. Future research should explore the impact of targeted financial and policy interventions in fostering vaccine confidence.

Indexed as

COVID-19COVID-19 VaccinesEthnicityFinancial StressMinority GroupsVaccination HesitancyAdultAgedCaliforniaClinical Trials, Phase IV as TopicFemaleHumansLatent Class AnalysisMaleMiddle AgedMulticenter Studies as TopicCOVID-19 Vaccinescommunity-based participatory researcheconomic hardshipVaccine hesitancy

Identifiers

PMID40637161
PMCPMC12247110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.